Quadruple therapy in the treatment of refractory peptic ulcer
-
摘要: 目的 探讨四联疗法治疗难治性消化性溃疡临床疗效.方法 86例难治性消化性溃疡患者随机分为治疗组43例,克拉霉素、替硝唑、埃索美拉唑加甘草酸铋散的四联疗法治疗；对照组43例,克拉霉素、替硝唑、埃索美拉唑三联疗法治疗.比较2组治疗后临床症状改善情况、溃疡愈合率、幽门螺杆菌清除率.结果 治疗组治疗后溃疡愈合率、幽门螺杆菌清除率明显高于对照组.所有患者均未发生明显不良反应.结论 四联疗法治疗难治性消化性溃疡临床疗效显著,无明显不良反应.
-
-
Venerito M, Wex T, Malfertheiner P. Helicobacter pylori related and non-related lesions in the stomach [J]. Minerva Gastroenterologica E Dietologica, 2011(4):395. Sebekina OV, Trubitsyna IE, Masharova AA. Clinical variants of chronic urticaria associated with Helicobacter pylori [J]. Eksp Klin Gastroenterol, 2011(5):20. 韶红, 孙立新, 张翠云. 两种四联疗法治疗幽门螺杆菌阳性消化溃疡疗效比较 [J]. 武警医学院学报, 2008(9):756. Chaturvedi R, de Sablet T, Coburn LA. Arginine and polyamines in Helicobacter pylori-induced immune dysregulation and gastric carcinogenesis [J]. Amino Acids, 2011. 杨柳青, 陈建婷. 以埃索美拉唑为核心的四联疗法根除幽门螺杆菌35例临床观察 [J]. 陕西医学杂志, 2011(7):918.doi: 10.3969/j.issn.1000-7377.2011.07.079. Selgrad M, Bornschein J, Malfertheiner P. Guidelines for treatment of Helicobacter pylori in the East and West [J]. Expert Review of Anticancer Therapy, 2011(8):581. Guo X, Zhao BH, Zhang MX. Risk factors of Helicobacter pylori infection among adults in northern China [J]. Hepato-Gastroenterology, 2011, (106):306. Luther J, Chey WD, Saad RJ. A clinician's guide to salvage therapy for persistent Helicobacter pylori infection [J]. Hosp Praet (Minneap), 2011(1):133. Felga G, Silva FM, Barbuti RC. Clarithromycinbased triple therapy for Helicobacter pylori treatment in pepticulcer patients [J]. J Infect Dev Ctries, 2010, (11):712. Haziri A, Juniku-Shkololli A, Gashi Z. Helicobacter pylori infection and precancerous lesions of the stomach [J]. Medicinski Arhiv, 2010(4):248.
计量
- 文章访问数: 202
- HTML全文浏览量: 48
- PDF下载量: 7
下载:
苏公网安备 32100302010246号
